The National Assembly of France is anticipated to grant final approval on Wednesday to a significant piece of legislation that will enable adults with incurable illnesses to access lethal medication. This move comes as part of an ongoing discussion regarding end-of-life care, which has persisted over several years. The lower house is widely predicted to endorse the measure, having previously expressed support in three readings, thereby concluding the parliamentary process on the proposal initially introduced by President Emmanuel Macron in 2019.

This proposed law primarily facilitates medically assisted suicide by permitting patients to receive and independently administer lethal medication, contingent upon strict regulations. Assistance from medical professionals, such as doctors or nurses, would only be available for individuals whose physical limitations hinder them from self-administering the medication.

Before becoming effective, the law will undergo a review by the Constitutional Council, which is likely to be requested to evaluate its constitutionality once approval is secured.

Senate’s Rejection and the Legislative Process

Despite support in the National Assembly, the Senate, which is dominated by conservatives, rejected the legislation that would align France with other European nations allowing assisted suicide or euthanasia under specific conditions. According to the legislative framework in France, the National Assembly holds the final authority when there is a disagreement between the two houses.

Senate President Gerard Larcher and Prime Minister Sebastien Lecornu indicated plans to refer the bill to the Constitutional Council, which will be given a month to determine its constitutional adherence. Lecornu noted that extensive discussions in the National Assembly provided a broader examination of the bill, contrasting with the Senate’s evaluation, which might not adequately address the diverse perspectives surrounding its implementation.

Under the stipulations of the bill, individuals seeking to end their lives must be at least 18 years old and either French citizens or legal residents. A physician must first consult a team of healthcare experts to ascertain that the individual suffers from a serious, incurable condition threatening their life. The patient must be in an advanced or terminal state, enduring pain that cannot be alleviated or is intolerable, all while requesting the lethal medication voluntarily.

Criteria for Eligibility and Process

Lawmakers have clarified that psychological suffering on its own will not suffice as a criterion for medically assisted dying, excluding individuals with severe mental health disorders or neurodegenerative diseases like Alzheimer’s. Those wishing to proceed must make their requests personally, which will then be reviewed by healthcare professionals within 15 days, followed by a mandatory decision period of at least two days.

If validated, the patient would be able to administer the lethal medication in a setting of their choosing, such as at home or in a healthcare facility, with the option to have loved ones present. On the designated date, a medical professional must confirm the patient’s wish to proceed and remain on standby for any possible complications. The costs associated with these procedures will be fully covered by France’s national health insurance system.

A 2023 study revealed that a majority of the French populace supports the legalisation of end-of-life options, with opinion polls indicating increasing backing over the past twenty years. The Association for the Right to Die With Dignity expressed that this law would empower individuals to make informed decisions concerning unbearable suffering.

However, opposition claims suggest that such measures may inadvertently pressure vulnerable populations. An anti-euthanasia organisation, Alliance Vita, argued in an open letter to Macron that a focus on immediate palliative care is necessary and that presenting death as a viable solution undermines human dignity.

Long or Short, get news the way you like. No ads. No redirections. Download Newspin and Stay Alert, The CSR Journal Mobile app, for fast, crisp, clean updates!

App Store –  https://apps.apple.com/in/app/newspin/id6746449540 

Google Play Store – https://play.google.com/store/apps/details?id=com.inventifweb.newspin&pcampaignid=web_share